Literature DB >> 11175335

Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain.

K Hara1, H Kudoh, T Enomoto, Y Hashimoto, T Masuko.   

Abstract

GP125/CD98 is a heterodimeric 125-kDa glycoprotein, which consists of an 85-kDa heavy chain (hc) and a 40-kDa light chain (lc), and is strongly expressed on the cell surface of various tumor cells, irrespective of their tissue of origin. We have recently demonstrated that overexpression of the CD98hc cDNA causes malignant transformation of NIH3T3 cells. To investigate the function of the extracellular domain of CD98hc in cell proliferation and malignant transformation, we established two NIH3T3-derived clones transfected with human truncated CD98hc cDNAs, and compared their characteristics with parental NIH3T3 and clones transfected with full-length CD98hc cDNA. Truncated as well as full-length CD98hc-transfected clones grew to a higher saturation density than control cells. Efficiency of colony formation in soft agar was augmented in all CD98hc-transfected clones, and the degrees of augmented colony formation of the transfectants expressing full-length CD98hc of 529 a.a. or truncated CD98hc of 418 a.a. were reduced by anti-human CD98hc antibodies, while that of the transfectant expressing truncated CD98hc of 237 a.a. lacking the epitopes recognized by anti-human CD98hc antibodies was not affected by the addition of antibodies. CD98hc-transfected clones developed tumors in athymic mice, and tumor growth of truncated CD98hc-transfected clones was faster than that of full-length CD98hc-transfected clones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175335     DOI: 10.1038/sj.onc.1204019

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Metabolic activation-related CD147-CD98 complex.

Authors:  Daosong Xu; Martin E Hemler
Journal:  Mol Cell Proteomics       Date:  2005-05-18       Impact factor: 5.911

2.  CD98hc (SLC3A2) mediates integrin signaling.

Authors:  Chloe C Feral; Naoyuki Nishiya; Csilla A Fenczik; Heidi Stuhlmann; Marina Slepak; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

3.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

4.  xCT expression reduces the early cell cycle requirement for calcium signaling.

Authors:  Michele Lastro; Antonis Kourtidis; Kate Farley; Douglas S Conklin
Journal:  Cell Signal       Date:  2007-11-07       Impact factor: 4.315

5.  Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.

Authors:  Kazue Masuko; Shogo Okazaki; Mayumi Satoh; Goh Tanaka; Tatsuya Ikeda; Ryota Torii; Eri Ueda; Takashi Nakano; Masaaki Danbayashi; Tomoyo Tsuruoka; Yoshiya Ohno; Hideki Yagi; Noritsugu Yabe; Hideaki Yoshida; Tomoyuki Tahara; Shiro Kataoka; Taichi Oshino; Takayuki Shindo; Shin-ichiro Niwa; Takatsugu Ishimoto; Hideo Baba; Yoshiyuki Hashimoto; Hideyuki Saya; Takashi Masuko
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

6.  CD98 increases renal epithelial cell proliferation by activating MAPKs.

Authors:  Nada Bulus; Chloe Feral; Ambra Pozzi; Roy Zent
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

7.  Dominant Suppression of β1 Integrin by Ectopic CD98-ICD Inhibits Hepatocellular Carcinoma Progression.

Authors:  Bo Wu; Yang Zhou; Yu Wang; Xiang-Min Yang; Zhen-Yu Liu; Jiang-Hua Li; Fei Feng; Zhi-Nan Chen; Jian-Li Jiang
Journal:  Int J Mol Sci       Date:  2016-11-10       Impact factor: 5.923

8.  Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein.

Authors:  K Itoh; K Inoue; K Hirooka; K Maruyama; M Ohkawa; K Matsui; H Tada; T Enomoto; Y Hashimoto; T Suzuki; T Masuko
Journal:  Jpn J Cancer Res       Date:  2001-12

9.  Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.

Authors:  Shiho Ueda; Hidemi Hayashi; Takako Miyamoto; Shinya Abe; Kana Hirai; Kanji Matsukura; Hideki Yagi; Yuta Hara; Kinji Yoshida; Shogo Okazaki; Masakazu Tamura; Yuki Abe; Toshinori Agatsuma; Shin-Ichiro Niwa; Kazue Masuko; Takashi Masuko
Journal:  Cancer Sci       Date:  2019-01-04       Impact factor: 6.716

10.  Overexpression of CD98 in intestinal epithelium dysregulates miRNAs and their targeted proteins along the ileal villus-crypt axis.

Authors:  Moon K Han; Mark Baker; Yuchen Zhang; Chunhua Yang; Mingzhen Zhang; Pallavi Garg; Emilie Viennois; Didier Merlin
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.